← Open Payments lookup

RAVIKUMAR KANNEGANTI: Open Payments

NPI 1679643191 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,773 in 94 payments from 14 companies in 2025. Trend: 2023 $2,517 · 2024 $1,560 · 2025 $1,773

Food & beverage: $1,773
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.18$534
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$260
Otsuka America Pharmaceutical, Inc.12$206
E.R. Squibb & Sons, L.L.C.10$201
Teva Pharmaceuticals USA, Inc.13$194
Axsome Therapeutics, Inc.5$91
Tris Pharma Inc4$66
Collegium Pharmaceutical, Inc.3$60
Corium, LLC6$50
Supernus Pharmaceuticals, Inc.1$30

Products named: INGREZZA, CAPLYTA, COBENFY, REXULTI, UZEDY, AUSTEDO XR, Auvelity, Jornay PM.

Industry payments across TX — which companies pay providers there.